Clinical Trial Update: A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CPTX2309, an investigational therapy, evaluating safety in healthy participants and in individuals with rheumatoid arthritis o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CPTX2309

Snippet

Sponsor: Capstan Therapeutics | Conditions: Healthy Volunteers, Rheumatoid Arthritis | Phase 1 | Status: RECRUITING